Europe eClinical Solutions Market – Industry Trends and Forecast to 2026

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE ECLINICAL SOLUTIONS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 EUROPE ECLINICAL SOLUTIONS MARKET: GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 DBMR MARKET POSITION GRID

2.8 MULTIVARIATE MODELING

2.9 PRODUCTS LIFELINE CURVE

2.10 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 INCREASING ADOPTION OF CLINICAL TRIALS

3.1.2 RISING GOVERNMENT INITIATIVES

3.1.3 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATION

3.1.4 INCREASE IN R & D EXPENDITURE BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES

3.2 RESTRAINTS

3.2.1 DEARTH OF TRAINED PROFESSIONALS

3.2.2 HIGH IMPLEMENTATION COST

3.3 OPPORTUNITIES

3.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS

3.3.2 TECHNOLOGICAL ADVANCEMENT

3.4 CHALLENGES

3.4.1 STRINGENT REGULATIONS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 EUROPE ECLINICAL SOLUTIONS MARKET, BY PRODUCT

6.1 OVERVIEW

6.2 ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS)

6.3 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM)

6.4 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS)

6.5 ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA)

6.6 ELECTRONIC TRIAL MASTER FILE SYSTEM

6.7 SAFETY SOLUTIONS

6.8 REGULATORY INFORMATION MANAGEMENT SOLUTIONS

6.9 CLINICAL DATA INTEGRATION PLATFORMS

6.10 CLINICAL ANALYTICS PLATFORMS

6.11 OTHER ECLINICAL SOLUTIONS

7 EUROPE ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE

7.1 OVERVIEW

7.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS

7.3 CLOUD-BASED (SAAS) SOLUTIONS

7.4 LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS

8 EUROPE ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE

8.1 OVERVIEW

8.2 PHASE III

8.3 PHASE II

8.4 PHASE IV

8.5 PHASE I

9 EUROPE ECLINICAL SOLUTIONSMARKET, BY END USER

9.1 OVERVIEW

9.2 HOSPITALS/HEALTHCARE PROVIDERS

9.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)

9.4 ACADEMIC INSTITUTES

9.5 PHARMA & BIOTECH ORGANIZATIONS

9.6 MEDICAL DEVICE MANUFACTURERS

9.7 CONSULTING SERVICE COMPANIES

10 EUROPE ECLINICAL SOLUTIONS MARKET, BY GEOGRAPHY

10.1 EUROPE

10.1.1 GERMANY

10.1.2 U.K.

10.1.3 ITALY

10.1.4 FRANCE

10.1.5 RUSSIA

10.1.6 SWITZERLAND

10.1.7 NETHERLANDS

10.1.8 SPAIN

10.1.9 TURKEY

10.1.10 BELGIUM

10.1.11 REST OF EUROPE

11 EUROPE ECLINICAL SOLUTIONS MARKET, COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: EUROPE

12 COMPANY PROFILE

12.1 ORACLE

12.1.1 COMPANY SNAPSHOT

12.1.2 REVENUE ANALYSIS

12.1.3 COMPANY SHARE ANALYSIS

12.1.4 PRODUCT PORTFOLIO

12.1.5 RECENT DEVELOPMENTS

12.2 MEDIDATA SOLUTIONS

12.2.1 COMPANY SNAPSHOT

12.2.2 REVENUE ANALYSIS

12.2.3 COMPANY SHARE ANALYSIS

12.2.4 PRODUCT PORTFOLIO

12.2.5 RECENT DEVELOPMENT

12.3 PAREXEL INTERNATIONAL CORPORATION

12.3.1 COMPANY SNAPSHOT

12.3.2 COMPANY SHARE ANALYSIS

12.3.3 PRODUCT PORTFOLIO

12.3.4 RECENT DEVELOPMENTS

12.4 BIOCLINICA

12.4.1 COMPANY SNAPSHOT

12.4.2 PRODUCT PORTFOLIO

12.4.3 RECENT DEVELOPMENTS

12.5 ERT CLINICAL

12.5.1 COMPANY SNAPSHOT

12.5.2 PRODUCT PORTFOLIO

12.5.3 RECENT DEVELOPMENTS

12.6 ARIS EUROPE

12.6.1 COMPANY SNAPSHOT

12.6.2 PRODUCT PORTFOLIO

12.6.3 RECENT DEVELOPMENTS

12.7 ADVARRA

12.7.1 COMPANY SNAPSHOT

12.7.2 PRODUCT PORTFOLIO

12.7.3 RECENT DEVELOPMENTS

12.8 ANJU SOFTWARE

12.8.1 COMPANY SNAPSHOT

12.8.2 PRODUCT PORTFOLIO

12.8.3 RECENT DEVELOPMENTS

12.9 BIO-OPTRONICS, INC

12.9.1 COMPANY SNAPSHOT

12.9.2 PRODUCT PORTFOLIO

12.9.3 RECENT DEVELOPMENTS

12.10 DATATRAK INT.

12.10.1 COMPANY SNAPSHOT

12.10.2 REVENUE ANALYSIS

12.10.3 SOLUTION PORTFOLIO

12.10.4 RECENT DEVELOPMENTS

12.11 ECLINICALWORKS

12.11.1 COMPANY SNAPSHOT

12.11.2 PRODUCT PORTFOLIO

12.11.3 RECENT DEVELOPMENTS

12.12 ECLINICAL SOLUTIONS LLC

12.12.1 COMPANY SNAPSHOT

12.12.2 PRODUCT PORTFOLIO

12.12.3 RECENT DEVELOPMENTS

12.13 IBM CORPORATION

12.13.1 COMPANY SNAPSHOT

12.13.2 REVENUE ANALYSIS

12.13.3 PRODUCT PORTFOLIO

12.13.4 RECENT DEVELOPMENT

12.14 ICON PLC

12.14.1 COMPANY SNAPSHOT

12.14.2 REVENUE ANALYSIS

12.14.3 SERVICE PORTFOLIO

12.14.4 RECENT DEVELOPMENTS

12.15 MASTERCONTROL, INC.

12.15.1 COMPANY SNAPSHOT

12.15.2 SOLUTION PORTFOLIO

12.15.3 RECENT DEVELOPMENTS

12.16 MAXISIT

12.16.1 COMPANY SNAPSHOT

12.16.2 PRODUCT PORTFOLIO

12.16.3 RECENT DEVELOPMENT

12.17 OMNICOMM SYSTEMS, INC

12.17.1 COMPANY SNAPSHOT

12.17.2 REVENUE ANALYSIS

12.17.3 PRODUCT PORTFOLIO

12.17.4 RECENT DEVELOPMENTS

12.18 RESONANCE HEALTH

12.18.1 COMPANY SNAPSHOT

12.18.2 REVENUE ANALYSIS

12.18.3 PRODUCT PORTFOLIO

12.18.4 RECENT DEVELOPMENTS

12.19 REALTIME

12.19.1 COMPANY SNAPSHOT

12.19.2 PRODUCT PORTFOLIO

12.19.3 RECENT DEVELOPMENT

12.20 SIGNANT HEALTH

12.20.1 COMPANY SNAPSHOT

12.20.2 SOLUTION PORTFOLIO

12.20.3 RECENT DEVELOPMENTS

12.21 VEEVA SYSTEMS

12.21.1 COMPANY SNAPSHOT

12.21.2 REVENUE ANALYSIS

12.21.3 COMPANY SHARE ANALYSIS

12.21.4 PRODUCT PORTFOLIO

12.21.5 RECENT DEVELOPMENT

12.22 XYBION CORPORATION

12.22.1 COMPANY SNAPSHOT

12.22.2 PRODUCT PORTFOLIO

12.22.3 RECENT DEVELOPMENTS

13 QUESTIONNAIRE

14 RELATED REPORTS

UU

TABLE 1 CLINICAL TRIAL CONDUCTED IN DIFFERENT LOCATIONS

TABLE 2 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE

TABLE 3 EUROPE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 4 EUROPE ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 5 EUROPE RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 6 EUROPE CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 7 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 8 EUROPE ELECTRICAL TRIAL MASTER FILE SYSTEM IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 EUROPE SAFETY SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 10 EUROPE REGULATORY INFORMATION MANAGEMENT SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 EUROPE CLINICAL DATA INTEGRATION PLATFORMS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 12 EUROPE CLINICAL ANALYTICS PLATFORMS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 EUROPE OTHER ECLINICAL SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 14 EUROPE ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 15 EUROPE WEB-HOSTED (ON-DEMAND) SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 16 EUROPE CLOUD-BASED (SAAS) SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 EUROPE LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 18 EUROPE ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 19 EUROPE PHASE III IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 EUROPE PHASE II IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 EUROPE PHASE IV IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 22 EUROPE PHASE I IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 EUROPE ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 24 EUROPE HOSPITALS/HEALTHCARE PROVIDERS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 25 EUROPE CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 EUROPE ACADEMIC INSTITUTES COMPANIES IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 27 EUROPE PHARMA & BIOTECH ORGANIZATIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 EUROPE MEDICAL DEVICE MANUFACTURERS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 EUROPE CONSULTING SERVICE COMPANIES IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 EUROPE ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 31 EUROPE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 32 EUROPE ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 33 EUROPE ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 34 EUROPE ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 35 GERMANY ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 36 GERMANY ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 37 GERMANY ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 38 GERMANY ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 39 U.K. ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 40 U.K. ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 41 U.K. ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 42 U.K. ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 43 ITALY ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 44 ITALY ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 45 ITALY ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 46 ITALY ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 47 FRANCE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 48 FRANCE ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 49 FRANCE ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 50 FRANCE ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 51 RUSSIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 52 RUSSIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 53 RUSSIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 54 RUSSIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 55 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 56 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 57 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 58 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 59 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 60 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 61 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 62 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 63 SPAIN ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 64 SPAIN ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 65 SPAIN ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 66 SPAIN ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 67 TURKEY ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 68 TURKEY ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 69 TURKEY ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 70 TURKEY ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 71 BELGIUM ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 72 BELGIUM ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 73 BELGIUM ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 74 BELGIUM ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 75 REST OF EUROPE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)